Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03403192 · ClinicalTrials.gov registry record · NA
EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery
A NA study of Thoracic Injuries, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
- 1
- Study location
NCT03403192: Completed NA study of Thoracic Injuries, sponsored by Wake Forest University Health Sciences.
NCT03403192 is a NA study of Thoracic Injuries that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 163 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03403192, a NA study of Thoracic Injuries, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the positional stability and quality of lung isolation provided by the EZ-blocker compared to a DLT for both right and left sided thoracic surgery. An additional objective will be to assess time to placement of both devices and other significant clinical differences between these two approaches to placement of the bronchial blocker (BB) including airway injury and post-operatives sore throat, post-operative hoarseness, Additionally we would like to examine the preoperative high resolution CT imaging data to determine if there are anatomic landmarks that may potentially inform the appropriateness or inappropriateness of choosing an EZ-blocker or left sided DLT.
Primary Outcome
Positional stability of lung isolation by measuring number of replacements due to device moving too deep or too shallow (proximal) within the lung.
Conditions Studied
Interventions
- DEVICE EZ-Blocker
- DEVICE DLT
Study Locations (1)
North Carolina
- Wake Forest Baptist Hospital - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2018-01-26 |
| Est. Completion | 2019-10-29 |
| Phase | NA |
What the finished NCT03403192 record still lists
NCT03403192 is an interventional study that assigns participants to a tested intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Thoracic Injuries appearing as the primary indexed condition, and to 2 interventions - of which EZ-Blocker is the first listed.
NCT03403192 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03403192 about?
NCT03403192 is a clinical study titled "EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery". The objective of this study is to evaluate the positional stability and quality of lung isolation provided by the EZ-blocker compared to a DLT for both right and left sided thoracic surgery. An additional objective will be to assess time to placement of both devices and other significant clinical d...
What is the current status of trial NCT03403192?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2018-01-26. Estimated completion is 2019-10-29.
What conditions does trial NCT03403192 study?
This clinical trial studies the following conditions: Thoracic Injuries.
What interventions are being tested in trial NCT03403192?
The interventions under investigation include: EZ-Blocker (DEVICE), DLT (DEVICE).
Who is sponsoring clinical trial NCT03403192?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03403192 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracic Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03403192's enrollment target sits among peer trials
163 627th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI